CLINICAL_TRIALS
ClinicalTrials.gov record update
Effect of Ocoxin®-Viusid® Nutritional Supplement on the Quality of Life of Patients With Advanced Stomach Cancer and Esophagogastric Junction. Phase II Clinical Trial.
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03549494
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:58.917596+00:00
- Published At
- 2024-02-07T00:00:00+00:00
- Record Updated At
- 2024-02-07
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Stomach Neoplasm", "Gastrointestinal Neoplasms", "Digestive System Neoplasm", "Esophageal Neoplasms", "Head and Neck Neoplasms", "Gastrointestinal Disease", "Digestive System Disease", "Esophageal Diseases", "Stomach Diseases", "Esophagogastric Junction Disorder"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-02-07"- protocolSection.identificationModule.nctId
"NCT03549494"- protocolSection.identificationModule.officialTitle
"Effect of Ocoxin\u00ae-Viusid\u00ae Nutritional Supplement on the Quality of Life of Patients With Advanced Stomach Cancer and Esophagogastric Junction. Phase II Clinical Trial."- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.